AGN-195183

AGN 195183 is a potent and selective agonist of RAR? (Kd=3 nM) with improved binding selectivity relative to AGN 193836; no activity on RAR?/?. IC50 value: 3 nM (Kd) ; 200 nM (EC80, RAR Trans.) Target: RAR? agonist Compound 4 (AGN-195183) inhibited the growth of breast cancer cell lines, and was inactive in an in vivo model of topical irritation. Compound 4 (AGN 195183) is currently in Phase I/IIA clinical trials in cancer patients. Compound 4 and ATRA inhibit growth of the human breast cancer cell lines, T-47D and SK-BR-3, however it does not cause the topical irritation induced by the RARa-selective retinoid, Am-580.